Conferences - Results from #10060

AUGS 2012 - Prevalence of urinary incontinence in an inner-city population - Session Highlights October 5, 2012

AUGS 2012 - Gestational diabetes and urinary incontinence later in life - Session Highlights October 5, 2012

AUGS 2012 - Does the impact of urinary incontinence on quality of life differ based on age? - Session Highlights October 5, 2012

AUGS 2012 - Evaluation of the quality of life improvements at six months in subjects with overactive bladder randomized to Interstim® therapy implant versus standard medical therapy - Session Highlights October 4, 2012

AUGS 2012 - The urinary microbiome in participants with urgency incontinence randomized to anticholinergic versus botulinum toxin-A in the ABC trial - Session Highlights October 4, 2012

AUGS 2012 - Anticholinergic versus botulinum toxin-A comparison trial for the treatment of urinary incontinence: The ABC randomized trial - Session Highlights October 4, 2012

AUGS 2012 - The cost of preoperative urodynamics: A secondary analysis of the ValUE trial - Session Highlights October 4, 2012

AUGS 2012 - The effect of urodynamic testing on clinical diagnosis, treatment plan and outcome in women undergoing stress urinary incontinence surgery - Session Highlights October 4, 2012

AUGS 2012 - The natural history of urinary incontinence in a nurses’ health study - Session Highlights October 4, 2012

WMSM 2012 - Nitric oxide-releasing polymeric microspheres as a therapy for erectile dysfunction - Slide Presentation September 10, 2012

WMSM 2012 - Peyronie’s disease: Intralesional therapy - Slide Presentation September 10, 2012

WMSM 2012 - Male cancers and specific requests for sexual care: Lessons for daily practice based on 3 prospective surveys in an outpatient urology clinic in public hospital - Poster September 8, 2012

WMSM 2012 - Cancer and sexuality: A specific survey in 320 health care professionals in order to specify the perceived needs for information or training - Session Highlights September 7, 2012

WMSM 2012 - Sexual dysfunction in the prostate cancer patient - Session Highlights September 6, 2012

WMSM 2012 - Determining the optimal erectile function domain score cutoff after radical prostatectomy (RP) - Session Highlights September 6, 2012

WMSM 2012 - Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction following prostate biopsy - Session Highlights September 6, 2012

WMSM 2012 - Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men one year following surgical treatment for localized prostate cancer - Session Highlights September 5, 2012

WMSM 2012 - Nitric oxide-releasing polymeric microspheres as a therapy for erectile dysfunction - Session Highlights September 5, 2012

ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Slide Presentation June 25, 2012

ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Editor's Commentary June 25, 2012

Page 504 of 524